Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
62 participants
INTERVENTIONAL
2016-08-02
2017-04-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study hypothesis is that intervention group participants will have a greater increase in autonomous motivation for weight loss than participants in the control group at 12 weeks.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Implementation Intentions to Self-incentivise Weight-loss
NCT03522727
The Healthy Weigh Study
NCT02878343
Testing Strategies to Encourage Weight Loss in an Employer Setting
NCT01208350
Using Social Incentives and Gamification for Weight Loss Promotion
NCT02564445
Worksite Wellness Randomized Controlled Trial
NCT02593240
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Weekly Incentive
Participants in the Weekly Incentive arm will be asked to weigh in each week during a 12 week intervention period. They will receive tailored messages and have an opportunity to win a financial reward each week they meet their weight loss goal. Participants will be asked to complete a final weight measurement at week 24.
Weekly Incentive
The tailored incentives intervention aims to assess the impact of tailored messaging and financial incentives on weight loss among obese employees.
Weekly Weigh-In
Participants in the Weekly Weigh-In arm will be asked to weigh in each week during a 12 week intervention period. Participants will be asked to complete a final weight measurement at week 24.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Weekly Incentive
The tailored incentives intervention aims to assess the impact of tailored messaging and financial incentives on weight loss among obese employees.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body Mass Index between 30 and 40 kg/m2
* Have wireless internet at home
* Have Android or iOS smart device
* Willing to record themselves weighing in on a scale or let a family member record them weighing in on a scale
Exclusion Criteria
* Taking medication (other than metformin) for diabetes to control blood sugar
* Having a serious psychiatric diagnosis, unstable medical conditions or experienced a heart attack or stroke in the past 6 months
* Having a history of drug or alcohol abuse or addiction to prescription medications
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jeffrey T. Kullgren
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeffrey T Kullgren, MD,MS,MPH
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Michigan
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUM00107647
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.